170 related articles for article (PubMed ID: 14562113)
1. B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.
Bertrand FE; Spengeman JD; Shah N; LeBien TW
Leukemia; 2003 Dec; 17(12):2454-9. PubMed ID: 14562113
[TBL] [Abstract][Full Text] [Related]
2. Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein.
Bertrand FE; Vogtenhuber C; Shah N; LeBien TW
Blood; 2001 Dec; 98(12):3398-405. PubMed ID: 11719380
[TBL] [Abstract][Full Text] [Related]
3. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT
Blood; 2003 Jul; 102(1):262-8. PubMed ID: 12637319
[TBL] [Abstract][Full Text] [Related]
4. LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia.
von Bergh AR; Beverloo HB; Rombout P; van Wering ER; van Weel MH; Beverstock GC; Kluin PM; Slater RM; Schuuring E
Genes Chromosomes Cancer; 2002 Sep; 35(1):92-6. PubMed ID: 12203795
[TBL] [Abstract][Full Text] [Related]
5. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).
Taki T; Kano H; Taniwaki M; Sako M; Yanagisawa M; Hayashi Y
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14535-40. PubMed ID: 10588740
[TBL] [Abstract][Full Text] [Related]
6. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
7. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.
Joh T; Hosokawa Y; Suzuki R; Takahashi T; Seto M
Oncogene; 1999 Jan; 18(4):1125-30. PubMed ID: 10023690
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
[TBL] [Abstract][Full Text] [Related]
11. Cryptic splice site activation during RNA processing of MLL/AF4 chimeric transcripts in infants with t(4;11) positive ALL.
Divoky V; Trka JM; Watzinger F; Lion T
Gene; 2000 Apr; 247(1-2):111-8. PubMed ID: 10773450
[TBL] [Abstract][Full Text] [Related]
12. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
[TBL] [Abstract][Full Text] [Related]
13. Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23).
Hiwatari M; Taki T; Taketani T; Taniwaki M; Sugita K; Okuya M; Eguchi M; Ida K; Hayashi Y
Oncogene; 2003 May; 22(18):2851-5. PubMed ID: 12743608
[TBL] [Abstract][Full Text] [Related]
14. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG
Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
De Zen L; Bicciato S; te Kronnie G; Basso G
Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Uckun FM; Herman-Hatten K; Crotty ML; Sensel MG; Sather HN; Tuel-Ahlgren L; Sarquis MB; Bostrom B; Nachman JB; Steinherz PG; Gaynon PS; Heerema N
Blood; 1998 Aug; 92(3):810-21. PubMed ID: 9680349
[TBL] [Abstract][Full Text] [Related]
17. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.
Kersey JH; Wang D; Oberto M
Leukemia; 1998 Oct; 12(10):1561-4. PubMed ID: 9766500
[TBL] [Abstract][Full Text] [Related]
18. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.
Ma C; Staudt LM
Blood; 1996 Jan; 87(2):734-45. PubMed ID: 8555498
[TBL] [Abstract][Full Text] [Related]
19. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
Mullighan CG; Kennedy A; Zhou X; Radtke I; Phillips LA; Shurtleff SA; Downing JR
Leukemia; 2007 Sep; 21(9):2000-9. PubMed ID: 17597811
[TBL] [Abstract][Full Text] [Related]
20. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
